HIMS Hims & Hers Health
- 14.035
- +0.195+1.41%
- 14.050
- +0.015+0.11%
Hims & Hers Health News
Hims & Hers Welcomes Anja Manuel, Foreign Policy Expert, Domestic Regulations Advisor, and Former Diplomat to Its Board of Directors
Manuel joins Hims & Hers board of directors to help the company further innovate and increase access to healthcare for millions within the personalized health and wellness space Hims & Hers Health, Inc.
High Insider Ownership Growth Stocks On US Exchange For May 2024
Earnings Estimates Rising for Hims & Hers Health (HIMS): Will It Gain?
Investors Heavily Search Hims & Hers Health, Inc. (HIMS): Here Is What You Need to Know
Hims & Hers Health(HIMS.US) Officer Sells US$30,861.99 in Common Stock
$Hims & Hers Health(HIMS.US)$ Officer Boughton Soleil sold 2,503 shares of common stock on May 13, 2024 at an average price of $12.33 for a total value of $30,861.99.Source: Announcement What is state
Hims & Hers Health(HIMS.US) Director Sells US$49,320 in Common Stock
$Hims & Hers Health(HIMS.US)$ Director Pendarvis Christiane sold 4,000 shares of common stock on May 13, 2024 at an average price of $12.33 for a total value of $49,320.Source: Announcement What is st
Analysts Offer Insights on Healthcare Companies: Avita Medical (RCEL), Inotiv (NOTV) and Hims & Hers Health (HIMS)
Insider Sale: Chief Medical Officer of Hims & Hers Health Inc (HIMS) Sells Shares
Hims & Hers Health(HIMS.US) Officer Sells US$130K in Common Stock
$Hims & Hers Health(HIMS.US)$ Officer Carroll Patrick Harrison sold 10,000 shares of common stock on May 9, 2024 at an average price of $13 for a total value of $130K.Source: Announcement What is stat
Is Hims & Hers Health Stock a Buy?
Goldman Screens for Growth Stocks With a Near-term Path to Profitability
Hims & Hers Health Shares Are Trading Higher on Continued Strength After the Company on Monday Reported Better-than-expected Q1 Financial Results and Issued Q2 and FY24 Revenue Guidance Above Estimates.
Hims & Hers Health Shares Are Trading Higher on Continued Strength After the Company on Monday Reported Better-than-expected Q1 Financial Results and Issued Q2 and FY24 Revenue Guidance Above Estimate
Form 144 | Hims & Hers Health(HIMS.US) Officer Proposes to Sell 130K in Common Stocks
SEC FILLINGS DISCLOSED/ May 9, $Hims & Hers Health(HIMS.US)$ Officer Carroll Patrick Harrison intends to sell 10,000 shares of its common stock on May 9, with a total market value of approximately $13
Hims & Hers Health: A Balanced View Amidst Growth and Scalability Concerns
US stocks close | Federal Reserve officials eagle, NASDAQ falls back, Tesla falls nearly 4%
The Dow Index recorded its longest continuous rise in more than four months. After the Reddit market, Disney fell 9.5% and Palantir fell 15%; after the results, the China Securities Index fell more than 2% and fell twice in a row. Xiaopeng Motors fell more than 6%, and Ideal Auto fell more than 3%.
Why Beyond Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Beyond, Inc. (NYSE:BYON) fell sharply during Tuesday's session following weaker-than-expected quarterly results.Beyond posted adjusted loss of $1.22 per share, versus estimates for a loss of
Why Hims & Hers Health Stock Is Rising Today
Hims and Hers Health Inc. (NYSE:HIMS) shares are up Tuesday after the company reported better-than-expected first quarter financial results.The Details: After the market close on Monday, Hims & Hers H
Hims & Hers Health's Model 'Proving Effective': 2 Analysts Examine Q1 Earnings
Shares of Hims & Hers Health Inc (NYSE:HIMS) were climbing in early trading on Tuesday. The personal-care products company reported upbeat results for the first quarter.The results be reported amid an
Oscar Health, Kenvue, Hims & Hers: Health Earnings Roundup
Tempur Sealy Posts Upbeat Earnings, Joins FibroGen, Coca-Cola Consolidated, Fabrinet And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were higher, with the Dow Jones gaining over 80 points on Tuesday.Shares of Tempur Sealy International, Inc. (NYSE:TPX) rose sharply during Tuesday's session following upbeat quarterly ear
Analysis
Price Target
No Data
